步长制药：12月24日召开董事会会议

Group 1 - The core point of the article is that Buchang Pharma announced a board meeting to discuss an investment proposal related to Shandong Buchang Zhongxin Kang Pharmaceutical Technology Co., indicating ongoing strategic initiatives within the company [1] - For the year 2024, Buchang Pharma's revenue composition is heavily weighted towards the pharmaceutical industry, accounting for 99.71%, while other business segments contribute only 0.29% [1] - As of the report, Buchang Pharma's market capitalization stands at 17.4 billion yuan [1]